Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis
International Journal of Molecular Sciences · 30.10.2026 · 27 (21) · 9736
DOI: 10.3390/ijms27219736 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2026. Verfasst von Yongkang Qiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biological Science and Technology, Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Guangdong Zhuhai-Ma…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Fibroblasts, Drug Repositioning, Transcriptome. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Provincial Natural Science Foundation, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is characterized by persistent fibroblast activation and excessive extracellular matrix deposition. However, transcriptional heterogeneity associated with translation- and RNA-binding protein (RBP)-related processes within IPF fibroblasts remains incompletely characterized. Here, we analyzed two independent human IPF single-cell RNA-sequencing cohorts to identify fibroblast states that differed in Translation/RBP-related transcriptional programs while sharing high fibrotic output. Donor-paired pseudobulk analysis in GSE136831 identified a transcriptional signature distinguishing these states, and genes showing consistent directional changes in the independent GSE135893 cohort were retained to derive a cross-cohort signature. Reverse-connectivity analysis across CLUE, L1000CDS2, and iLINCS was then used to prioritize compounds predicted to transcriptionally oppose this signature. Candidate compounds were subsequently evaluated in transforming growth factor-β1 (TGF-β1)-stimulated human fetal lung fibroblasts (HFL-1), with cell viability, α-smooth muscle actin (α-SMA), and collagen I used for initial phenotypic assessment. PP-1, PK-11195, dabrafenib, GSK-1059615, and dasatinib reduced both profibrotic markers within the tested concentration ranges, identifying them as candidates for further investigation. Together, these findings define a cross-cohort Translation/RBP-related fibroblast signature in IPF and support its use as a transcriptome-guided strategy for prioritizing compounds with antifibrotic phenotypic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biological Science and Technology, Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Guangdong Zhuhai-Macao Joint Biotech Laboratory, Department of Biology, Faculty of Arts a…
- School of Pharmacy, Mudanjiang Medical University, Mudanjiang 157011, China.
ORCID-Profile: Yongkang Qiao
Förderung
- Guangdong Provincial Natural Science Foundation
- Beijing Natural Science Foundation
Zitieren
APA
Qiao, Y., Cui, C., Han, Y., Tang, X., Yang, Z., & Ge, C. (2026). Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences, 27(21), 9736. https://doi.org/10.3390/ijms27219736
Vancouver
Qiao Y, Cui C, Han Y, Tang X, Yang Z, Ge C. Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 2026;27(21):9736. doi:10.3390/ijms27219736
BibTeX
@article{Qiao2026,
author = {Qiao, Yongkang and Cui, Chaoyue and Han, Yanhong and Tang, Xinxin and Yang, Zhen and Ge, Chuang},
title = {Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9736},
doi = {10.3390/ijms27219736}
}
EUVIMED